Onconova Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Onconova Therapeutics Inc
TickerTRAW
CIK #0001130598
CUSIP68232V884
SectorLife Sciences - Pharmaceutical Preparations
Address375 Pheasant Run, Newtown, PA 18940
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Traws Pharma Inc 2024-04-16 14.0 M Exemption: 506(b) · Duration: One year or less · Commission: $1,039,500 · Revenue: Decline to Disclose
Onconova Therapeutics Inc 2019-06-04 0.5 M Exemption: 506(b) · Minimum: $500,000 · Remaining: $1,500,000 · Duration: One year or less · Revenue: $1 - $1,000,000
CIK Filing 2011 - 2026
[0001130598] 10-K
[0001130598] 10-Q
[0001130598] 3
[0001130598] 4
[0001130598] 8-K
[0001130598] D
[0001130598] SC 13D
[0001130598] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Management LP Traws Pharma Inc [2026-02-12] 0.0
Chernett Jorey Traws Pharma Inc [2026-01-16] 0.0
Adage Capital Management LP Traws Pharma Inc [2025-05-12] 0.0
Ikarian Capital LLC Traws Pharma Inc [2025-02-14] 0.0
Alyeska Investment Group LP Traws Pharma Inc [2025-02-14] 0.0
Ayrton Capital LLC Traws Pharma Inc [2025-02-13] 0.0
Perceptive Advisors LLC Traws Pharma Inc [2025-01-08] 0.0
OrbiMed Advisors LLC Traws Pharma Inc [2024-09-23] 19.9
Viriom Inc Traws Pharma Inc [2024-04-08] 6.5
CVI Investments Inc Onconova Therapeutics Inc [2021-10-01] 5.7
Lincoln Park Capital Fund LLC Onconova Therapeutics Inc [2021-01-08] 6.52
Armistice Capital LLC Onconova Therapeutics Inc [2020-01-10] 4.99
Armistice Capital LLC Onconova Therapeutics Inc [2019-12-19] 4.99
Intracoastal Capital LLC Onconova Therapeutics Inc [2019-12-02] 4.99
Point72 Asset Management LP Onconova Therapeutics Inc [2019-11-26] 0.99
Sabby Management LLC Onconova Therapeutics Inc [2019-09-27] 2.52
Armistice Capital LLC Onconova Therapeutics Inc [2019-09-26] 4.99
EcoR1 Capital LLC Onconova Therapeutics Inc [2018-05-07] 0.99
Armistice Capital LLC Onconova Therapeutics Inc [2018-02-20] 0.0
683 Capital Management LLC Onconova Therapeutics Inc [2018-02-16] 21.8
Sabby Management LLC Onconova Therapeutics Inc [2017-05-01] 7.61
Reddy E Premkumar Onconova Therapeutics Inc [2016-08-19] 5.8
Tyndall Capital Partners L P Onconova Therapeutics Inc [2016-08-18] 13.5
Baxalta Inc Onconova Therapeutics Inc [2016-02-12] 0.6
Reddy E Premkumar Onconova Therapeutics Inc [2016-02-11] 5.84
Frigate Ventures LP Onconova Therapeutics Inc [2016-01-13] 7.1
Baxalta Inc Onconova Therapeutics Inc [2015-05-11] 12.0
Reddy E Premkumar Onconova Therapeutics Inc [2015-02-11] 6.32
Reddy E Premkumar Onconova Therapeutics Inc [2014-02-14] 6.35
Baxter International Inc Onconova Therapeutics Inc [2013-08-09] 12.2
Hoffman Michael B Onconova Therapeutics Inc [2013-08-02] 21.4
Form 3/4/5 Filer 2011 - 2026
OrbiMed Advisors LLC
OrbiMed Capital GP VIII LLC
Traws Pharma Inc
Parker Charles Nolan
Dukes Iain D
Stover Jack E
Redfield Robert
Leaman John Harold
Cautreels Werner
Pauza Charles David
Savchuk Nikolay
Clarke Trafford
Shoemaker Mary Teresa
TPAV LLC
Guerin Mark Patrick
Brennan Nora
Greenwood Luba
Viriom Inc
Fruchtman Steven M
Moyo Victor M
Atadja Peter
Mehta Viren
Groopman Jerome
Marino James J
Gelder Mark S MD
OLER Abraham N
Hoffman Michael B
Reddy E Premkumar
Woodman Richard Charles
Maniar Manoj
Tyndall Capital Partners L P
Armistice Capital Master Fund Ltd
Boyd Steven
Armistice Capital LLC
Zweiman Ari
683 Capital Partners LP
683 Capital Management LLC
Kumar Ramesh
Bienen Henry S
McKearn Thomas J
Bansal Ajay
Vanlent Anne
Baxter Healthcare SA
Baxalta GmbH
Baxalta Inc
Michael & Jane Hoffman 2013 Descendants
Altland James
Baxter International Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Stover Jack E
Stock Option (right to buy) · derivative
2026-03-08 Grant 33,435 $0.00
Redfield Robert
Stock Option (right to buy) · derivative
2026-03-08 Grant 108,854 $0.00
Clarke Trafford
Stock Option (right to buy) · derivative
2026-03-08 Grant 33,435 $0.00
Shoemaker Mary Teresa
Stock Option (right to buy) · derivative
2026-03-08 Grant 33,435 $0.00
Pauza Charles David
Stock Option (right to buy) · derivative
2026-03-08 Grant 118,367 $0.00
Dukes Iain D
Stock Option (right to buy) · derivative
2026-03-08 Grant 231,336 $0.00
Leaman John Harold
Stock Option (right to buy) · derivative
2026-03-08 Grant 33,435 $0.00
Savchuk Nikolay
Stock Option (right to buy) · derivative
2026-03-08 Grant 96,899 $0.00
Cautreels Werner
Stock Option (right to buy) · derivative
2026-03-08 Grant 31,258 $0.00
Cautreels Werner
Common Stock
2025-12-12 Grant 4,874 $0.00
Shoemaker Mary Teresa
Common Stock
2025-12-12 Grant 6,157 $0.00
Pauza Charles David
Stock Option (right to purchase) · derivative
2025-12-12 Grant 73,886 $0.00
Leaman John Harold
Common Stock
2025-12-12 Grant 4,058 $0.00
Stover Jack E
Common Stock
2025-12-12 Grant 6,157 $0.00
Stover Jack E
Stock Option (right to purchase) · derivative
2025-12-12 Grant 24,629 $0.00
Cautreels Werner
Stock Option (right to purchase) · derivative
2025-12-12 Grant 19,496 $0.00
Redfield Robert
Stock Option (right to purchase) · derivative
2025-12-12 Grant 65,676 $0.00
Clarke Trafford
Stock Option (right to purchase) · derivative
2025-12-12 Grant 24,629 $0.00
Savchuk Nikolay
Common Stock
2025-12-12 Grant 16,419 $0.00
Shoemaker Mary Teresa
Stock Option (right to purchase) · derivative
2025-12-12 Grant 24,629 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 28 3,619,802
2025-12-31 22 3,418,593
2025-09-30 18 1,304,595
2025-06-30 20 1,263,487
2025-03-31 20 1,732,327
2024-12-31 19 1,170,406
2024-09-30 12 646,363
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com